GiACTA-trial-tocilizumab-actemra-for-giant-cell-arteritis-gca

The GiACTA trial: Tocilizumab in Giant Cell Arteritis

Stone et al. Trial of Tocilizumab in Giant-Cell Arteritis. N. Engl. J. Med. 2017 377(4):317-328. NEJM Quick Take:  Click on the following link from the New England Journal of Medicine to view a 2 minute video summarizing the study results: video. Game changer:  Why is this study important? Tocilizumab is the first treatment, other than corticosteroids, shown […]

The GiACTA trial: Tocilizumab in Giant Cell Arteritis Read More »